Gore's endovascular graft-repair device gains wider FDA nod

W.L. Gore has achieved a broader FDA approval for its endovascular graft-repair device. The Flagstaff, AZ, company's TAG thoracic endoprosthesis won regulators' blessing for use in acute and chronic Type B dissections of the descending thoracic aorta. Translated, the device is now the only one to win FDA backing for use in aneurysm, trauma and dissection. Surgeons deliver the device via a cathether, by way of a small groin incision. After that, it is guided up the leg artery, through the abdomen, into the chest and finally the implantation site. Item

Suggested Articles

Digital molecule designer Insilico Medicine has launched a new preclinical research program focused on treatments for brain cancer.

Ortho Clinical Diagnostics has launched a new chemistry system to complete its integrated Vitros XT line of laboratory solutions.

Synthetic DNA weaver Twist Bioscience announced a handful of new collaborations this week amidst a $140 million raise from an underwritten offering.